Zurich Cantonal Bank’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $369K | Buy |
+15,028
| New | +$492K | ﹤0.01% | 1987 |
|
|
2025
Q4 | – | Sell |
-12,207
| Closed | -$394K | – | 2812 |
|
|
2025
Q3 | $278K | Buy |
12,207
+118
| +1% | +$2.4K | ﹤0.01% | 2036 |
|
|
2025
Q2 | $247K | Buy |
12,089
+8
| +0.1% | +$148 | ﹤0.01% | 2035 |
|
|
2025
Q1 | $242K | Sell |
12,081
-1,561
| -11% | -$38.6K | ﹤0.01% | 1995 |
|
|
2024
Q4 | $364K | Buy |
13,642
+4,166
| +44% | +$127K | ﹤0.01% | 1820 |
|
|
2024
Q3 | $270K | Sell |
9,476
-406
| -4% | -$10.3K | ﹤0.01% | 1947 |
|
|
2024
Q2 | $215K | Buy |
9,882
+952
| +11% | +$21.2K | ﹤0.01% | 2004 |
|
|
2024
Q1 | $198K | Buy |
8,930
+738
| +9% | +$16.1K | ﹤0.01% | 2055 |
|
|
2023
Q4 | $177K | Buy |
8,192
+1,395
| +21% | +$24.6K | ﹤0.01% | 2153 |
|
|
2023
Q3 | $115K | Buy |
6,797
+2,909
| +75% | +$50.9K | ﹤0.01% | 2292 |
|
|
2023
Q2 | $53.3K | Hold |
3,888
| – | – | ﹤0.01% | 2601 |
|
|
2023
Q1 | $88.3K | Hold |
3,888
| – | – | ﹤0.01% | 2355 |
|
|
2022
Q4 | $91.5K | Sell |
3,888
-36
| -0.9% | -$835 | ﹤0.01% | 2326 |
|
|
2022
Q3 | $102K | Sell |
3,924
-57
| -1% | -$1.6K | ﹤0.01% | 2206 |
|
|
2022
Q2 | $87K | Sell |
3,981
-194
| -5% | -$4.51K | ﹤0.01% | 2336 |
|
|
2022
Q1 | $187K | Sell |
4,175
-901
| -18% | -$37.2K | ﹤0.01% | 1928 |
|
|
2021
Q4 | $218K | Sell |
5,076
-75
| -1% | -$3.92K | ﹤0.01% | 2010 |
|
|
2021
Q3 | $343K | Sell |
5,151
-16
| -0.3% | -$1.13K | ﹤0.01% | 1545 |
|
|
2021
Q2 | $379K | Buy |
5,167
+160
| +3% | +$10.6K | ﹤0.01% | 1388 |
|
|
2021
Q1 | $343K | Buy |
5,007
+3,132
| +167% | +$235K | ﹤0.01% | 1460 |
|
|
2020
Q4 | $126K | Hold |
1,875
| – | – | ﹤0.01% | 2108 |
|
|
2020
Q3 | $96K | Buy |
+1,875
| New | +$83.4K | ﹤0.01% | 2006 |
|
Other funds holding CSTL
RI
PCM
VCM
SPPAM
VPM
